Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGUFICBIO
resources
GUFICBIO

Gufic Biosciences Ltd.

NSE: GUFICBIO
BSE: 509079
Sector: Healthcare
Industry: Pharmaceuticals
391.80-2.2 (-0.56%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Gufic Biosciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Gufic Biosciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General23 Oct 2026
    Intimation Regarding USFDA Pre-Approval Inspection At The Company'S Manufacturing Facility Situated At Indore, Madhya Pradesh
    Intimation regarding USFDA Pre-Approval Inspection at the Company''s Manufacturing facility situated at Indore, Madhya Pradesh is attached herewith.
  2. Newspaper Publication17 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 is attached herewith
  4. General29 Sept 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith
  5. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Intimation of closure of Trading Window is attached herewith
  6. General28 Sept 2026
    Intimation Of Environmental, Social And Governance ('ESG') Rating
    Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith
  7. General24 Sept 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith
  8. Credit Rating8 Sept 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Intimation of Credit Rating is attached herewith
  9. AGM7 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Voting Results and Consolidated Scrutinizer Report of 42nd Annual General Meeting of the Company held on Friday, September 04, 2026 is attached herewith
  10. AGM4 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of the 42nd Annual General Meeting of the Company held on Friday, September 04, 2026 is attached herewith
  11. General2 Sept 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Promotion And Change In Designation Of Senior Management Personnel
    Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
  12. Newspaper Publication18 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
  13. Analyst / Investor Meet17 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Intimation of Audio Recording of Earnings Conference Call held on August 17, 2026 at 04:30 p.m. is attached herewith
  14. Newspaper Publication15 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 is attached herewith.
  15. Acquisition14 Aug 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Approval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
  16. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Meeting Held On Friday, August 14, 2026
    Outcome of the Board of Directors Meeting held on Friday, August 14, 2026 is attached herewith.
  17. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
  18. Business Responsibility and Sustainability Reporting (BRSR)12 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2026, is attached herewith
  19. Reg. 34 (1) Annual Report12 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
  20. Record Date12 Aug 2026
    Intimation Of Record Date For Final Dividend And 42Nd Annual General Meeting
    Intimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31, 2026

Frequently Asked Questions

Where can I download the annual report of Gufic Biosciences Ltd.?
Annual reports of Gufic Biosciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Gufic Biosciences Ltd.?
Quarterly earnings results and presentations of Gufic Biosciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Gufic Biosciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Gufic Biosciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Gufic Biosciences Ltd.?
Investor presentations and annual day presentations of Gufic Biosciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Gufic Biosciences Ltd.?
Corporate announcements and regulatory filings of Gufic Biosciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Gufic Biosciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Gufic Biosciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Gufic Biosciences Ltd.?
The ISIN (International Securities Identification Number) of Gufic Biosciences Ltd. is INE742B01025. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Gufic Biosciences Ltd. listed?
Gufic Biosciences Ltd. is listed on NSE and BSE. The NSE symbol is GUFICBIO and the BSE code is -.
Where can I find the shareholding pattern of Gufic Biosciences Ltd.?
The quarterly shareholding pattern of Gufic Biosciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Gufic Biosciences Ltd. on Sharpely?
Share price data for Gufic Biosciences Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.